Evidence map›Paper›PMID 32294906›Full record

ArticleJournal of clinical medicine2020

Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation.

Charat Thongprayoon, Wisit Kaewput, Karthik Kovvuru, Panupong Hansrivijit, Swetha R Kanduri, Tarun Bathini, Api Chewcharat, Napat Leeaphorn, Maria L Gonzalez-Suarez, Wisit Cheungpasitporn

Open access · goldAbstract readEditorial
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Performance of ChatGPT on Nephrology Test Questions.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
  9. Review
  10. Review
  11. Ethical Implications of Chatbot Utilization in Nephrology.Journal of personalized medicine · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Charat ThongprayoonDivision of Nephrology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Wisit KaewputDepartment of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok 10400, Thailand.
Karthik KovvuruDivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Panupong HansrivijitDepartment of Internal Medicine, University of Pittsburgh Medical Center Pinnacle, Harrisburg, PA 17105, USA.
Swetha R KanduriDivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Tarun BathiniDepartment of Internal Medicine, University of Arizona, Tucson, AZ 85721, USA.
Api ChewcharatDivision of Nephrology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Napat LeeaphornDepartment of Nephrology, Department of Medicine, Saint Luke's Health System, Kansas City, MO 64111, USA.
Maria L Gonzalez-SuarezDivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Wisit CheungpasitpornDivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
University of Mississippi Medical Center · USMayo Clinic in Arizona · USPhramongkutklao Hospital · THSaint Luke's Health System · USUniversity of Arizona · USUPMC Central Pa · US

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 2016 to 2025
$38.2M
NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

Kidney diseases form part of the major health burdens experienced all over the world. Kidney diseases are linked to high economic burden, deaths, and morbidity rates. The great importance of collecting a large quantity of health-related data among human cohorts, what scholars refer to as "big data", has increasingly been identified, with the establishment of a large group of cohorts and the usage of electronic health records (EHRs) in nephrology and transplantation. These data are valuable, and can potentially be utilized by researchers to advance knowledge in the field. Furthermore, progress in big data is stimulating the flourishing of artificial intelligence (AI), which is an excellent tool for handling, and subsequently processing, a great amount of data and may be applied to highlight more information on the effectiveness of medicine in kidney-related complications for the purpose of more precise phenotype and outcome prediction. In this article, we discuss the advances and challenges in big data, the use of EHRs and AI, with great emphasis on the usage of nephrology and transplantation.

Indexed as

acute kidney injuryartificial intelligencebig datachronic kidney diseasekidney transplantationmachine learningnephrologytransplantation

Identifiers

PMID32294906
PMCPMC7230205
OpenAlexW3016180486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.